Patrick J. McEnany, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 562,000 shares at $23.55 ($13.1M) on 2024-11-11, disclosed to the SEC on 2024-11-13.
Open-market sale of $13.1M CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.55 | 230,000 | $5.4M | 41.2% |
| 2 | $23.20 | 192,000 | $4.5M | 33.9% |
| 3 | $23.42 | 70,000 | $1.6M | 12.5% |
| 4 | $23.42 | 70,000 | $1.6M | 12.5% |
| Total | $23.40 avg | 562,000 | $13.1M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |
| CPRX | SELL | 2022-11-22 | $7.8M | — | Filing → |